<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00810108713265</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713265</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABK125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.514Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713272</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713272</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABK500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.490Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713289</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713289</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABK999</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.472Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713395</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713395</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABN008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.273Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713401</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713401</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABN015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713418</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713418</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABN125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.216Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713425</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713425</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABN500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.189Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713432</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713432</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABN999</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713470</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713470</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABZ008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.078Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713487</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713487</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABZ015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.054Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713494</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713494</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABZ125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.025Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713500</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713500</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABZ500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.000Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713517</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713517</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABZ999</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:55.972Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108714149</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108714149</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AGL008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:54.294Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108714156</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108714156</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AGL015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:54.263Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108714163</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108714163</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AGL125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:54.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108714170</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108714170</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AGL250</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:54.213Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108716969</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108716969</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PAL008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:06.957Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108716976</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108716976</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PAL015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:06.925Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108716983</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108716983</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PAL125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:06.909Z</lastUpdated>
  </row>
</eudamedExport>